6-OHDA |
6-hydroxydopamine |
AD |
Alzheimer’s diseases |
ARE |
Antioxidant response element |
BBB |
Blood–brain barrier |
DA |
Dopaminergic |
DAMPs |
Damage-associated molecular patterns |
EAE |
Experimental autoimmune encephalomyelitis |
GPx: |
Glutathione peroxidase |
LPS |
lipopolysaccharide |
MPTP |
1-methyl-4-phenyl-1: 2, 3, 6-tetrahydropyridine; |
MS |
Multiple sclerosis |
NF-κB |
Nuclear factor kappa light chain-enhancer of activated B cells |
Nrf2 |
Nuclear factor erythroid |
PAMPs |
Pathogen-associated molecular patterns |
PD |
Parkinson’s disease |
PRRs |
Pattern recognition receptors |
PTZ |
Pentylenetetrazol |
ROS |
Reactive oxygen species |
SOD |
Superoxide dismutase |
TBI |
Traumatic brain injury |
TH |
Tyrosine hydroxylase |
TLR |
Toll-like receptors |